Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Thomas

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Diabetes Care|February 21, 2023
Age of Diagnosis Does Not Alter the Presentation or Progression of Robustly Defined Adult-Onset Type 1 DiabetesNicholas J Thomas, Anita V Hill, Colin M Dayan, et al.
Journal of Clinical Epidemiology|November 11, 2022
Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approachesNicholas J Thomas, Andrew McGovern, Katherine G Young, et al.
Journal of Clinical Epidemiology|June 14, 2023
Corrigendum to 'Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches' [Journal of Clinical Epidemiology (2023) 34-44]Nicholas J Thomas, Andrew McGovern, Katherine G Young, et al.
Diabetologia|November 21, 2022
The impact of population-level HbA<sub>1c</sub> screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysisKatherine G Young, Andrew P McGovern, Inês Barroso, et al.
Diabetes, Obesity & Metabolism|January 6, 2025
Treatment outcomes with oral anti-hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): A population-based cohort studyRhian Hopkins, Katherine G Young, Nicholas J Thomas, et al.
Diabetologia|May 22, 2023
Correction to: The impact of population-level HbA<sub>1c</sub> screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysisKatherine G Young, Andrew P McGovern, Inês Barroso, et al.
Diabetologia|June 5, 2023
HbAKatherine G Young, Andrew P McGovern, Inês Barroso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2014
RETRACTED: CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistanceChanghwan Yoon, Do Joong Park, Benjamin Schmidt, et al.
Diabetes Care|October 24, 2020
Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020John M Dennis, Bilal A Mateen, Raphael Sonabend, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2024
Retraction: CD44 Expression Denotes a Subpopulation of Gastric Cancer Cells in Which Hedgehog Signaling Promotes Chemotherapy ResistanceChanghwan Yoon, Do Joong Park, Benjamin Schmidt, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Diabetes Care|February 21, 2023
Age of Diagnosis Does Not Alter the Presentation or Progression of Robustly Defined Adult-Onset Type 1 DiabetesNicholas J Thomas, Anita V Hill, Colin M Dayan, et al.
Journal of Clinical Epidemiology|November 11, 2022
Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approachesNicholas J Thomas, Andrew McGovern, Katherine G Young, et al.
Journal of Clinical Epidemiology|June 14, 2023
Corrigendum to 'Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches' [Journal of Clinical Epidemiology (2023) 34-44]Nicholas J Thomas, Andrew McGovern, Katherine G Young, et al.
Diabetologia|November 21, 2022
The impact of population-level HbA<sub>1c</sub> screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysisKatherine G Young, Andrew P McGovern, Inês Barroso, et al.
Diabetes, Obesity & Metabolism|January 6, 2025
Treatment outcomes with oral anti-hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): A population-based cohort studyRhian Hopkins, Katherine G Young, Nicholas J Thomas, et al.
Diabetologia|May 22, 2023
Correction to: The impact of population-level HbA<sub>1c</sub> screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysisKatherine G Young, Andrew P McGovern, Inês Barroso, et al.
Diabetologia|June 5, 2023
HbAKatherine G Young, Andrew P McGovern, Inês Barroso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2014
RETRACTED: CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistanceChanghwan Yoon, Do Joong Park, Benjamin Schmidt, et al.
Diabetes Care|October 24, 2020
Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020John M Dennis, Bilal A Mateen, Raphael Sonabend, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2024
Retraction: CD44 Expression Denotes a Subpopulation of Gastric Cancer Cells in Which Hedgehog Signaling Promotes Chemotherapy ResistanceChanghwan Yoon, Do Joong Park, Benjamin Schmidt, et al.
Pageof 5